432 related articles for article (PubMed ID: 11716366)
1. Inhibition of drug-induced Fas ligand transcription and apoptosis by Bcl-XL.
Biswas RS; Cha HJ; Hardwick JM; Srivastava RK
Mol Cell Biochem; 2001 Sep; 225(1-):7-20. PubMed ID: 11716366
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription.
Srivastava RK; Sasaki CY; Hardwick JM; Longo DL
J Exp Med; 1999 Jul; 190(2):253-65. PubMed ID: 10432288
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-treated baby hamster kidney cells.
Simizu S; Shibasaki F; Osada H
Jpn J Cancer Res; 2000 Jul; 91(7):706-14. PubMed ID: 10920278
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
Delgado M; Ganea D
J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
[TBL] [Abstract][Full Text] [Related]
5. Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells.
Srinivasan A; Li F; Wong A; Kodandapani L; Smidt R; Krebs JF; Fritz LC; Wu JC; Tomaselli KJ
J Biol Chem; 1998 Feb; 273(8):4523-9. PubMed ID: 9468507
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis.
Jayanthi S; Deng X; Ladenheim B; McCoy MT; Cluster A; Cai NS; Cadet JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):868-73. PubMed ID: 15644446
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase ctheta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death.
Villalba M; Kasibhatla S; Genestier L; Mahboubi A; Green DR; Altman A
J Immunol; 1999 Dec; 163(11):5813-9. PubMed ID: 10570264
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
9. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
Starcevic SL; Elferink C; Novak RF
J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788
[TBL] [Abstract][Full Text] [Related]
10. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L).
Huang DC; Hahne M; Schroeter M; Frei K; Fontana A; Villunger A; Newton K; Tschopp J; Strasser A
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14871-6. PubMed ID: 10611305
[TBL] [Abstract][Full Text] [Related]
11. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway.
Furuke K; Shiraishi M; Mostowski HS; Bloom ET
J Immunol; 1999 Feb; 162(4):1988-93. PubMed ID: 9973469
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.
Sjöström J; Blomqvist C; von Boguslawski K; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Wist E; Valvere V; Takayama S; Reed JC; Saksela E
Clin Cancer Res; 2002 Mar; 8(3):811-6. PubMed ID: 11895913
[TBL] [Abstract][Full Text] [Related]
13. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer.
Odoux C; Albers A; Amoscato AA; Lotze MT; Wong MK
Int J Cancer; 2002 Feb; 97(4):458-65. PubMed ID: 11802207
[TBL] [Abstract][Full Text] [Related]
14. Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4).
Gonçalves A; Braguer D; Carles G; André N; Prevôt C; Briand C
Biochem Pharmacol; 2000 Dec; 60(11):1579-84. PubMed ID: 11077039
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Walczak H; Bouchon A; Stahl H; Krammer PH
Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
[TBL] [Abstract][Full Text] [Related]
16. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression.
Bosque A; Pardo J; Martínez-Lorenzo MJ; Iturralde M; Marzo I; Piñeiro A; Alava MA; Naval J; Anel A
J Leukoc Biol; 2005 Apr; 77(4):568-78. PubMed ID: 15653751
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to apoptosis in insulin-like growth factor-I receptor-deficient brown adipocytes.
Valverde AM; Mur C; Brownlee M; Benito M
Mol Biol Cell; 2004 Nov; 15(11):5101-17. PubMed ID: 15356271
[TBL] [Abstract][Full Text] [Related]
19. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
[TBL] [Abstract][Full Text] [Related]
20. Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells.
Villunger A; Ghaffari-Tabrizi N; Tinhofer I; Krumböck N; Bauer B; Schneider T; Kasibhatla S; Greil R; Baier-Bitterlich G; Uberall F; Green DR; Baier G
Eur J Immunol; 1999 Nov; 29(11):3549-61. PubMed ID: 10556809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
